Clinical Trial Update: The Role of Vitamin K2 in Preventing Glucocorticoid-Induced Bone Loss in Children With Nephrotic Syndrome [NA]

View source ↗

Summary

A clinical trial sponsored by Ain Shams University is evaluating whether Vitamin K2 can prevent glucocorticoid-induced bone loss in children with nephrotic synd…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glucocorticoid-induced Osteoporosis
• Nephrotic Syndrome

Drugs mentioned

• Vitamin K2 (menaquinone)

Snippet

Sponsor: Ain Shams University | Conditions: Pediatrics Nephrology | NA | Status: RECRUITING